From May 19, 2023 to June 30, 2023, the company has repurchased 125,782 shares, representing 0.09% for $0.98 million. With this, the company has completed the repurchase of 125,782 shares, representing 0.09% for $0.98 million under the buyback announced on May 19, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.42 USD | -3.21% |
|
-3.39% | -40.57% |
06-12 | Cytek Biosciences to Seek M&A | CI |
06-12 | Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09:20 AM |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.57% | 711M | |
+4.85% | 212B | |
+9.86% | 188B | |
+31.11% | 157B | |
+34.08% | 114B | |
+3.65% | 64.01B | |
+19.45% | 54.88B | |
+1.63% | 48.83B | |
-3.12% | 39.3B | |
+1.93% | 35.97B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on May 19, 2023.